The benefit obtained from Keytruda plus chemotherapy in patients with persistent, recurrent or metastatic cervical cancer occurred regardless of whether they also received Avastin. Patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback